Gapping up
In reaction to strong earnings/guidance:
- DECK +5.8%, SYMC +5.8%, DGII +5.5%, PFPT +5.2%, CY +4.9%, SPR +4.3%, JCI +3.8%, XOM +3.7%, IDXX +3.3%, NVO +3.1%, SKYW +3%, YUMC +3%, SOHU +2.7%, RDY +2.6%, POST +2.4%, FMC +2.1%, MOD +1.8%, HON +1.7%, MRK +1.6%, TAK +1.4%, MSG +1.3%, D +1%, SNE +0.9%, HMC +0.7%
Other news:
- TTNP +80.5% (update on the U.S. commercial relaunch of Probuphine (buprenorphine) implant)
- GERN +8.7% (appoints Aleksandra Rizo, M.D., Ph.D. as Chief Medical Officer )
- BRX +3.3% (to join S&P MidCap 400)
- TEVA +1.2% (announces that the EMA's CHMP has recommended granting a marketing authorization for AJOVY 225 mg solution for injection in pre-filled syringe for the prophylaxis of migraine in adults who have at least four migraine days per month)
Analyst comments:
- SNAP +2.5% (upgraded to Hold at Cascend Securities)